相关实验视频
Updated: Sep 15, 2025

04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
7.9K
阿特里·金的不良影响:系统审查和案例系列
Magnus Chun1, Jenna Sutton1, Jessica Chung1
1From the Department of Internal Medicine, Kirk Kerkorian School of Medicine at University of Nevada, Las Vegas, Las Vegas.
Southern medical journal
|July 15, 2025
概括
阿特里金 (Artri King) 是一种非处方药的关节疼痛补充剂,含有未申报的类固醇和NSAIDs,导致严重的健康问题,如库辛综合征. 由于严重的不良反应,患者应警告不要使用它.
科学领域:
- 药物监督 药物监督 药物监督
- 内分泌学 在内分泌学.
- 综合医学是一个整体的医学.
背景情况:
- 阿特里金是一种非处方药,用于治疗关节疼痛,使用量越来越多.
- 该补充剂含有未申报的皮质类固醇 (德克萨米他) 和NSAIDs (迪克洛菲纳克),造成严重的健康风险.
- 人们对阿特里金的不良影响缺乏认识,需要进行系统审查.
结论:
- 严重的不良反应包括库辛综合征,上腺功能衰竭和恶化的高血糖症.
- 临床医生必须采取彻底的药物和补充史.
- 患者应被告知Artri King的风险,并建议不要使用它.
相关概念视频
Aortic Regurgitation III: Medical Management
47
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
47
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
513
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
513
Antihypertensive Drugs: Angiotensin II Receptor Blockers
930
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
930
Rheumatic Heart Disease I: Introduction
48
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
48
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
40
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40
Rheumatic Heart Disease III: Medical Management
35
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
35

